The Journal of Physical Chemistry Letters,
Journal Year:
2024,
Volume and Issue:
16(1), P. 396 - 405
Published: Dec. 31, 2024
Addressing
the
frequent
emergence
of
SARS-CoV-2
mutant
strains
requires
therapeutic
approaches
with
innovative
neutralization
mechanisms.
The
targeting
multivalent
nanobodies
can
enhance
potency
and
reduce
risk
viral
escape,
positioning
them
as
promising
drug
candidates.
Here,
synergistic
mechanisms
two
types
are
investigated
deeply.
Our
research
revealed
that
Fu2-1-Fu2-2
system
exhibited
significant
synergy,
whereas
Sb#15-Sb#68
demonstrated
antagonism,
in
which
entropy
was
dominant
contributor
to
antagonism.
Conformational
analysis
further
presence
a
monomeric
nanobody
influenced
flexibility
residues
near
other
epitopes,
thereby
affecting
overall
synergy
systems.
Moreover,
we
identified
changes
hydrogen
bond
network
charge
played
critical
role
binding
between
spike.
We
hope
this
study
will
provide
novel
insights
into
development
combinations.
The Journal of Physical Chemistry B,
Journal Year:
2024,
Volume and Issue:
128(14), P. 3340 - 3349
Published: April 2, 2024
The
emergence
of
the
variant
concern
Omicron
(B.1.1.529)
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
exacerbates
COVID-19
pandemic
due
to
its
high
contagious
ability.
Studies
have
shown
that
binds
human
ACE2
more
strongly
than
wild
type.
prevalence
in
new
cases
promotes
novel
lineages
with
improved
receptor
binding
affinity
and
immune
evasion.
To
shed
light
on
this
open
problem,
work,
we
investigated
free
energy
domain
BA.2,
BA.2.3.20,
BA.3,
BA4/BA5,
BA.2.75,
BA.2.75.2,
BA.4.6,
XBB.1,
XBB.1.5,
BJ.1,
BN.1,
BQ.1.1,
CH.1.1
using
all-atom
molecular
dynamics
simulation
mechanics
Poisson–Boltzmann
surface
area
method.
results
show
these
increased
compared
BA.1
lineage,
BA.2.75
BA.2.75.2
subvariants
bind
others.
However,
general,
affinities
do
not
differ
significantly
from
each
other.
electrostatic
force
dominates
over
van
der
Waals
interaction
between
cells.
Based
our
results,
argue
viral
evolution
does
further
improve
SARS-CoV-2
for
but
may
increase
Journal of Infection,
Journal Year:
2025,
Volume and Issue:
unknown, P. 106461 - 106461
Published: March 1, 2025
Highlights•The
Comirnaty
Omicron
XBB.1.5
vaccine
demonstrated
moderate
short-term
protection
against
infection
and
symptomatic
infection,
reaching
peak
effectiveness
between
2
to
5
weeks
post-vaccination.•Approximately
9
12
after
vaccination,
the
protective
effect
of
booster
declined
near
zero
both
infection.•The
BA.5
bivalent
showed
no
evidence
within
study
period,
with
estimates
wide
confidence
intervals
indicating
considerable
uncertainty.•These
findings
emphasize
need
for
adaptive
strategies
development
variant-targeted
vaccines
maintain
emerging
SARS-CoV-2
variants.AbstractBackgroundUnderstanding
over
time
is
critical
informing
strategies,
types,
public
health
policies,
particularly
continued
emergence
novel
variants.MethodsThe
Winter
Coronavirus
(COVID-19)
Infection
Study
(WCIS),
conducted
from
November
2023
March
2024,
involved
approximately
150,000
participants
aged
3
years
older
England
Scotland.
The
WCIS
tested
at
regular
using
lateral
flow
tests
estimate
prevalence
incidence
in
real-time.
Survival
analysis
Cox
proportional
hazards
regression
was
conducted,
data
linked
participant
vaccination
records,
evaluate
association
since
risk
infection.
Vaccine
(VE)
evaluated
those
65
old
over.
model
incorporated
time-varying
covariates
counting
process
framework,
stratified
baseline
by
age
group,
region,
time,
included
key
such
as
sex,
clinical
status,
ethnicity,
socioeconomic
indicators.
VE
estimated
hazard
ratios,
penalised
cubic
splines
were
used
capture
nonlinear
effects
vaccination.ResultsWe
that
peaked
day
14
post-vaccination,
70.63%
(95%
Confidence
Intervals
(CI):
43.33%,
84.78%)
63.62%
CI:
22.69%,
82.88%)
rapidly
9-12
post
point
close
uncertainty
60
onwards.
In
contrast,
crossing
zero.ConclusionsThese
provide
important
insights
into
targeted
context
an
evolving
pandemic.
As
continues
mutate,
approaches
design
policy
will
be
addressing
variants
protecting
high-risk
groups.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
14
Published: Jan. 10, 2024
Amid
the
ongoing
monkeypox
outbreak,
there
is
an
urgent
need
for
rapid
development
of
effective
therapeutic
interventions
capable
countering
immune
evasion
mechanisms
employed
by
virus
(MPXV).
The
strategy
involves
binding
F3L
protein
to
dsRNA,
resulting
in
diminished
interferon
(IFN)
production.
Consequently,
our
current
research
focuses
on
utilizing
virtual
drug
screening
techniques
target
RNA
domain
protein.
Out
954
compounds
within
South
African
natural
compound
database,
only
four
demonstrated
notable
docking
scores:
−6.55,
−6.47,
−6.37,
and
−6.35
kcal/mol.
dissociation
constant
(KD)
analysis
revealed
a
stronger
affinity
top
hits
1-4
(−5.34,
−5.32,
−5.29,
−5.36
kcal/mol)
with
MPXV.
All-atom
simulations
top-ranked
1
4
consistently
exhibited
stable
dynamics,
suggesting
their
potential
interact
effectively
interface
residues.
This
was
further
substantiated
through
analyses
parameters
such
as
radius
gyration
(Rg),
Root
Mean
Square
Fluctuation,
hydrogen
bonding.
Cumulative
assessments
free
energy
confirmed
top-performing
candidates
among
all
compounds,
values
−35.90,
−52.74,
−28.17,
−32.11
kcal/mol
1-4,
respectively.
These
results
indicate
that
hit
could
hold
significant
promise
advancing
innovative
therapies,
suitability
both
vivo
vitro
experiments.
Journal of Virology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 28, 2025
ABSTRACT
Angiotensin-converting
enzyme
2
(ACE2)
is
a
transmembrane
protein
known
for
its
physiological
role
in
the
renin-angiotensin
system
that
also
serves
as
receptor
entry
of
SARS-CoV-1,
SARS-CoV-2,
and
seasonal
human
coronavirus
NL63
(hCoV-NL63).
ACE2
contains
seven
N-linked
glycosylation
sites.
Molecular
simulation
binding
analyses
suggest
some
them
are
involved
interaction
with
Spike
(S)
proteins
hCoVs,
but
their
relevance
S-mediated
fusion
viral
poorly
investigated.
To
address
this,
we
determined
impact
all
sites
on
SARS-CoV-2
hCoV-NL63
infection
well
cell-to-cell
fusion.
We
found
mutant
expressed
localized
at
cell
surface,
albeit
lacks
glycans
decreased
levels.
On
average,
changes
T92I,
N322A,
N690A,
combined
mutation
increased
endocytic
VSVpp
mediated
by
early
HU-1
Omicron
BA.2,
BA.5,
XBB.1.5
S
proteins.
In
comparison,
only
lack
glycan
N322
enhanced
syncytia
formation
case
Changes
N90A,
N322A
strain
about
twofold
to
threefold
had
lesser
effects
genuine
variants.
Despite
reduced
surface
expression
ACE2,
elimination
usually
via
pathway
while
having
little
effect
presence
TMPRSS2.
Our
results
provide
insights
into
ability
(hACE2)
serve
receptors
infection.
IMPORTANCE
Several
coronaviruses
use
angiotensin-converting
primary
cells.
glycosylated
distinct
positions,
target
cells
incompletely
understood.
Here,
examined
individual
mutations
hACE2
Spike-mediated
VSV-pseudoparticle
new
information
highly
pathogenic
coronaviruses.
Pharmaceuticals,
Journal Year:
2025,
Volume and Issue:
18(4), P. 602 - 602
Published: April 21, 2025
Background:
Hypoxia
plays
a
key
role
in
cancer
progression,
mainly
by
stabilizing
and
activating
hypoxia-inducible
factor-1
(HIF-1).
For
HIF-1
to
function
under
low
oxygen
conditions,
it
must
interact
with
the
transcriptional
coactivator
p300,
critical
step
for
promoting
cell
survival
adaptation
hypoxic
environments.
Methods:
Consequently,
we
used
drug
design
molecular
simulation
techniques
screen
phytochemical
databases,
including
traditional
Chinese
African
medicine
sources,
compounds
that
could
disrupt
p300/HIF-1
interaction.
Results:
In
this
study,
identified
potential
high
docking
scores
such
as
EA-176920
(−8.719),
EA-46881231
(−8.642),
SA-31161
(−9.580),
SA-5280863
(−8.179),
NE-5280362
(−10.287),
NE-72276
(−9.017),
NA-11210533
(−10.366),
NA-11336960
(−7.818),
TCM-5281792
(−12.648),
TCM-6441280
(−9.470
kcal/mol)
lead
compounds.
Furthermore,
compound
highest
score
from
each
database
(EA-176920,
SA-31161,
NE-5280362,
NA-11210533,
TCM-5281792)
was
subjected
further
analysis.
The
stable
binding
affinity
of
these
p300
confirmed
Post-simulation
free
energy
(−22.0020
kcal/mol,
−25.4499
−32.4530
−33.9918
−57.7755
respectively)
KD
Moreover,
selected
followed
Lipinski
rules
favorable
ADMET
properties
like
efficient
intestinal
absorption,
water
solubility,
no
toxicity.
Conclusions:
Our
findings
highlight
natural
target
protein–protein
interactions
lay
groundwork
future
vitro
vivo
studies
explore
their
therapeutic
potential.
Specifically,
disrupting
interaction
interfere
hypoxia-driven
pathways
promote
tumor
growth,
angiogenesis,
metastasis,
offering
promising
strategy
suppress
progression
at
level.
The Journal of Physical Chemistry Letters,
Journal Year:
2024,
Volume and Issue:
15(3), P. 671 - 680
Published: Jan. 11, 2024
The
recent
discovery
that
TMEM106B
serves
as
a
receptor
mediating
ACE2-independent
SARS-CoV-2
entry
into
cells
deserves
attention,
especially
in
the
background
of
frequent
emergence
mutant
strains.
Here,
structure-dynamic
features
this
novel
pathway
are
dissected
deeply.
Our
investigation
revealed
large
loop
(RBD@471-491)
could
anchor
TMEM106B,
which
was
then
firmly
locked
by
another
(RBD@444-451).
and
widely
disseminated
Omicron
variants
(BA.2.86/EG.5.1)
affect
anchoring
recognition
proteins,
with
BA.2.86
being
more
likely
to
impact
limited
or
undetectable
ACE2
expression.
EG.5.1
variant
captures
poorly
due
impaired
electrostatic
complementarity.
Furthermore,
we
emphasize
antibody
design
against
these
two
loops
enhance
protection
low-expressing
according
alanine
scanning
mutagenesis
multiple
antibodies.
We
hope
study
will
provide
perspective
for
prevention
treatment
new
viral
invasion
pathway.
Frontiers in Chemistry,
Journal Year:
2024,
Volume and Issue:
11
Published: Jan. 16, 2024
SARS-CoV-2,
also
referred
to
as
severe
acute
respiratory
syndrome
coronavirus
2,
is
the
virus
responsible
for
causing
COVID-19,
an
infectious
disease
that
emerged
in
Wuhan,
China,
December
2019.
Among
its
crucial
functions,
NSP6
plays
a
vital
role
evading
human
immune
system
by
directly
interacting
with
receptor
called
TANK-binding
kinase
(TBK1),
leading
suppression
of
IFNβ
production.
Consequently,
present
study
we
used
structural
and
biophysical
approaches
analyze
effect
newly
mutations
on
binding
TBK1.
identified
mutations,
four
(F35G,
L37F,
L125F,
I162T)
were
found
significantly
destabilize
structure
NSP6.
Furthermore,
molecular
docking
analysis
highlighted
mutant
displayed
highest
affinity
TBK1,
exhibiting
scores
−1436.2
wildtype
−1723.2,
−1788.6,
−1510.2,
−1551.7
F35G,
I162T
mutants,
respectively.
This
suggests
potential
enhanced
evasion
capability
Particularly,
F35G
mutation
exhibited
strongest
affinity,
supported
calculated
free
energy
−172.19
kcal/mol.
To
disrupt
between
conducted
virtual
drug
screening
develop
novel
inhibitor
derived
from
natural
products.
From
this
screening,
top
5
hit
compounds
most
promising
candidates
score
−6.59
kcal/mol,
−6.52
−6.32
−6.22
−6.21
The
dynamic
simulation
3
hits
further
verified
stability
drugs-NSP6
complexes.
In
conclusion,
provides
valuable
insight
into
higher
infectivity
SARS-CoV-2
new
variants
strong
rationale
development
drugs
against
Journal of Infection and Public Health,
Journal Year:
2024,
Volume and Issue:
17(7), P. 102448 - 102448
Published: May 10, 2024
Influenza
A
virus
causes
severe
respiratory
illnesses,
especially
in
developing
nations
where
most
child
deaths
under
5
occur
due
to
lower
tract
infections.
The
RIG-I
protein
acts
as
a
sensor
for
viral
dsRNA,
triggering
interferon
production
through
K63-linked
poly-ubiquitin
chains
synthesized
by
TRIM25.
However,
the
influenza
virus's
NS1
hinders
this
process
binding
TRIM25,
disrupting
its
association
with
and
preventing
downstream
signalling,
contributing
evasion
of
immune
response.
In
our
study
we
used
structural-based
drug
designing,
molecular
simulation,
free
energy
approaches
identify
potent
phytocompounds
from
various
natural
product
databases
(>100,000
compounds)
able
inhibit
screening
identified
EA-8411902
EA-19951545
East
African
Natural
Products
Database,
NA-390261
NA-71
North
SA-65230
SA-
4477104
South
Compounds
NEA-
361
4524784
North-East
TCM-4444713
TCM-6056
Traditional
Chinese
Medicines
Database
top
hits.
docking
energies
results
revealed
that
these
compounds
have
high
affinity
specific
active
site
residues
(Leu95,
Ser99,
Tyr89)
involved
interaction
Additionally,
analysis
structural
dynamics,
energy,
dissociation
constants
demonstrates
notably
stronger
protein.
Moreover,
all
selected
exhibit
exceptional
ADMET
properties,
including
water
solubility,
gastrointestinal
absorption,
an
absence
hepatotoxicity,
while
adhering
Lipinski's
rule.
Our
simulation
findings
highlight
demonstrate
NS1-TRIM25
interaction,
adhere
drug-likeness
criteria,
thus
presenting
promising
candidates
further
development
antiviral
agents
against